Search Results

Displaying Results 1-1 of 1 "'CTMX'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs

Jul 06, 2026, 11:19 ET A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs

antibody-engineering, immune-engager, and platform-based discovery approaches include Xencor (NASDAQ: XNCR), CytomX Therapeutics (NASDAQ: CTMX), Zymeworks (NASDAQ: ZYME), and Nurix Therapeutics (NASDAQ: NRIX), each distinct, and none a proxy for GT Biopharma.Putting

More news about: American News Group

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.